Skip to content

Author

Leonard Azamfirei

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Healthcare Digital Twins Across Scales: A Narrative Review and Five-Level Conceptual Framework

Background/Objectives: Healthcare digital twins are being developed at scales ranging from individual organs to regional health systems. However, the literature at these different scales has largely evolved independently. This narrative review examines how the concept changes as the represented object grows, and proposes a five-level framework: physiological, patient, care-delivery, hospital and health-system twins proposed by the authors as an analytical framework. Methods: Web of Science, Scopus, PubMed and Google Scholar were searched between June and July 2026 for English-language records published from January 2022 onwards. Sources were eligible if they described a virtual representation of an identified physical counterpart in healthcare, updated from that counterpart’s own data and used to produce decision-relevant predictions. Editorials, abstract-only records, static models and work outside healthcare were excluded. The included literature was examined to identify recurring patterns in the representation and application of healthcare digital twins. These patterns informed the development of the authors’ proposed five-level conceptual framework. As no formal quality appraisal was undertaken, conclusions regarding evidence maturity and implementation should be interpreted cautiously. Results: Forty-four publications form the evidence base: 10 original studies, 26 reviews and 8 conceptual or consensus papers. Patient-specific applications were described primarily at the physiological and patient levels, particularly in cardiology and oncology. External validation remained uncommon, and prospective evaluation was rare across all five levels. Care-delivery twins were reported mainly in critical care, emergency and perioperative settings, whereas hospital and health-system applications were largely limited to prototypes and simulations. Conclusions: This review suggests that the challenges associated with healthcare digital twins evolve as applications move from physiological models to health-system settings. Beyond technical complexity, interoperability, organisational, governance and equity considerations become increasingly important. Prospective evidence of patient benefit, operational effectiveness and system-level impact remains limited across all five levels.

Leonard Azamfirei, D. Bica, Andrei Calin Dragomir et al. · 0 citations
Review Open access Aug 2026

Artificial Intelligence and Bioengineering Approaches for Antimicrobial Resistance Prediction

Background and Objectives: Antimicrobial resistance (AMR) is a major challenge, particularly in intensive care units, where broad-spectrum therapy is often initiated before microbiological confirmation. Artificial intelligence (AI) may improve AMR prediction, but its clinical value depends on integration with bioengineering-enabled digital microbiology. This narrative review examines how AI, bioengineering platforms and digital microbiology can support AMR prediction, clinical decision support and antimicrobial stewardship across the sample-to-decision pipeline. Materials and Methods: A targeted narrative review was conducted using PubMed/MEDLINE and Google Scholar. Publications from 2020 onward were prioritized, while earlier seminal studies, methodological frameworks and regulatory documents were included when relevant. Evidence was synthesized across AI-based resistance prediction, antimicrobial stewardship, digital microbiology and bioengineering technologies. Results: AI and machine-learning approaches showed promising performance in patient-level resistance prediction, pathogen-level susceptibility prediction and antimicrobial stewardship. For example, model discrimination reached an AUROC of 0.936 for carbapenem-resistant Klebsiella pneumoniae prediction, while model-guided empirical therapy in Enterobacterales bloodstream infections could have increased active beta-lactam therapy from 70% to 79%. However, most evidence remains retrospective and single-centre, with limited external or prospective validation. Conclusions: AI has considerable potential to support AMR prediction and antimicrobial stewardship, but current evidence primarily demonstrates technical feasibility rather than established clinical effectiveness. Broader implementation will require rigorous validation, integration into clinical workflows, continuous monitoring and demonstration of clinical benefit.

Oana Frandeș, Leonard Azamfirei, Oana-Elena Branea et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.